Best Probiotics by Strain & Condition

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Probiotic efficacy is strain-specific and condition-specific — results from one strain cannot be extrapolated to another. This guide does not recommend specific commercial products. Consult a qualified healthcare provider before starting any probiotic supplement, particularly if you are immunocompromised, pregnant, or taking medications.

Choosing the right probiotic can be overwhelming. With thousands of products on the market making broad claims, it is difficult to know which probiotics are actually supported by clinical evidence. The reality is that probiotic benefits are strain-specific and condition-specific — meaning a strain that helps with one condition may do nothing for another [mcfarland2021].

This guide cuts through the noise by organizing probiotic recommendations by strain and health condition, based on published clinical research. We have no affiliate relationships with any supplement brands.

How We Evaluate Probiotics

Our approach to evaluating probiotics is rooted in three principles [hill2014, sanders2019]:

1. Strain-level specificity matters. Benefits demonstrated for Lactobacillus rhamnosus GG cannot be assumed for other L. rhamnosus strains. We only cite evidence at the specific strain level — not the species level.

2. Human clinical trials take priority. While animal and in vitro studies provide mechanistic insights, we weight our recommendations toward strains with published human randomized controlled trials (RCTs) or systematic reviews.

3. Replication strengthens confidence. A single positive trial is a starting point, not a conclusion. Strains with multiple positive trials across different research groups carry more weight in our assessments.

What we do NOT consider:

• Marketing claims or brand reputation
• Celebrity endorsements
• Number of strains in a product (more is not inherently better)
• CFU count alone (the right dose depends on the strain)
• Affiliate compensation (we have none)

Best Probiotic Strains by Condition

The following table summarizes the most evidence-supported probiotic strains for common health goals. This is not exhaustive — it represents strains with the strongest and most consistent clinical evidence as of the latest systematic reviews [mcfarland2021, sanders2019].

Health Goal	Best-Studied Strain(s)	Key Evidence	Typical Dose
Acute diarrhea	Saccharomyces boulardii CNCM I-745	Multiple RCTs, Cochrane review	250-500 mg/day
Antibiotic-associated diarrhea	S. boulardii CNCM I-745; L. rhamnosus GG	Cochrane meta-analysis [goldenberg2017]	10-20 billion CFU
IBS (general)	B. infantis 35624	Multiple RCTs, AGA conditional recommendation	1 billion CFU
IBS (bloating)	L. plantarum 299v	RCTs showing reduced bloating	10 billion CFU
Immune support (URI prevention)	L. rhamnosus GG; B. lactis BB-12	Cochrane review [hao2015]	1-10 billion CFU
Vaginal health	L. rhamnosus GR-1 + L. reuteri RC-14	Multiple RCTs [reid2001]	1-2 billion CFU each
Metabolic health	Akkermansia muciniphila	Proof-of-concept RCT [depommier2019]	10 billion CFU (pasteurized)
C. difficile prevention	S. boulardii CNCM I-745	Cochrane review [goldenberg2017]	500 mg-1g/day

Important caveats: This table reflects current evidence, which continues to evolve. "Best-studied" does not mean "proven effective for everyone." Individual responses to probiotics vary based on existing microbiome composition, diet, genetics, and other factors [suez2019].

Best Probiotics for Digestive Health

Digestive health is the most well-studied application for probiotics, with the strongest evidence concentrated around a few specific strains [sanders2019, ford2018].

Saccharomyces boulardii CNCM I-745

This probiotic yeast — not a bacterium — has one of the most robust evidence profiles in all of probiotic research. Unlike bacterial probiotics, S. boulardii is naturally resistant to antibiotics, making it particularly useful during antibiotic therapy [goldenberg2017].

Evidence highlights:

• A Cochrane review of 21 RCTs found S. boulardii reduced the risk of antibiotic-associated diarrhea by approximately 50%
• Multiple trials show efficacy in reducing the duration and severity of acute infectious diarrhea
• May help prevent C. difficile recurrence when used alongside standard antibiotic therapy
• Generally well-tolerated; should be avoided in immunocompromised patients or those with central venous catheters

Typical dose: 250-500 mg (approximately 5-10 billion CFU) taken 1-2 times daily.

Lactobacillus rhamnosus GG

One of the most extensively studied probiotic strains worldwide, L. rhamnosus GG (often abbreviated LGG) has been the subject of over 300 clinical studies [szajewska2020].

Evidence highlights:

• Strong evidence for reducing the duration of acute gastroenteritis in children (multiple Cochrane reviews)
• Moderate evidence for preventing antibiotic-associated diarrhea in children and adults
• Some evidence for modest benefit in IBS symptoms, though results are mixed
• Well-characterized safety profile with decades of use

Typical dose: 10-20 billion CFU daily, though effective doses vary by condition.

Bifidobacterium infantis 35624

This strain has demonstrated the most consistent evidence specifically for IBS symptom relief [ford2018].

Evidence highlights:

• A well-designed RCT published in the American Journal of Gastroenterology showed significant improvement in abdominal pain, bloating, and bowel habit satisfaction versus placebo
• The American Gastroenterological Association (AGA) issued a conditional recommendation for this strain in IBS
• Effects appear to be dose-dependent, with 1 billion CFU showing the best results in some trials

Typical dose: 1 billion CFU daily.

For more on probiotic bacteria and how they differ from the bacteria already in your gut, see our detailed guide.

Best Probiotics for Immune Support

The gut houses approximately 70% of the body's immune cells, making the microbiome-immune connection a major area of probiotic research [hao2015].

Lactobacillus rhamnosus GG for upper respiratory infections

A 2015 Cochrane review of 12 RCTs found that probiotics, including LGG, were associated with a reduced incidence of upper respiratory tract infections (URIs) compared to placebo. The review found probiotics may reduce the number of people experiencing URI episodes and the average duration of illness, though the quality of evidence was rated low to moderate.

Bifidobacterium lactis BB-12

This strain has been studied in both children and adults for immune-related outcomes.

Evidence highlights:

• Several RCTs in daycare children showed reduced incidence of respiratory infections and antibiotic use
• Studies in elderly adults suggest potential enhancement of influenza vaccine response
• May increase secretory IgA levels, an important first-line immune defense at mucosal surfaces

Typical dose: 1-10 billion CFU daily, depending on the study.

Reality check: While the evidence for probiotics and immune function is promising, it remains modest in strength. Probiotics should be viewed as one potential component of immune support — not a replacement for vaccination, adequate sleep, regular exercise, and a balanced diet.

Best Probiotics for Women

Women's health applications represent a growing area of probiotic research, particularly for vaginal and urinary tract health [reid2001].

Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14

This specific two-strain combination has the strongest evidence for vaginal health among all probiotic formulations.

Evidence highlights:

• Multiple RCTs show oral supplementation can increase vaginal Lactobacillus colonization
• Studies suggest potential benefit as adjunctive therapy for bacterial vaginosis (BV), though not as a standalone treatment
• May help restore vaginal microbiome balance after antibiotic treatment for BV
• The oral route (not vaginal) was used in most positive trials — the strains migrate from the GI tract to the vaginal area

Typical dose: 1-2 billion CFU of each strain, taken orally once daily.

Considerations for women's probiotics:

• Pregnancy: L. rhamnosus GG and B. lactis BB-12 have been studied during pregnancy and are generally considered safe, though always consult your OB-GYN
• UTI prevention: Some evidence suggests L. rhamnosus GR-1 + L. reuteri RC-14 may reduce UTI recurrence, but the evidence is not strong enough for routine recommendation
• Menopause: Research is emerging on how the gut microbiome influences estrogen metabolism (the "estrobolome"), but specific probiotic recommendations for menopause are premature

What to Look for in a Probiotic Supplement

If you decide to try a probiotic, the following criteria may help you evaluate products [reid2018, hill2014]:

1. Strain identification on the label The label should list the full strain designation (e.g., Lactobacillus rhamnosus GG), not just the genus and species. Without the strain designation, you cannot verify whether the product matches strains studied in clinical trials.

2. CFU count guaranteed through expiration Look for products that guarantee CFU count "through end of shelf life" or "at expiration," not "at time of manufacture." Probiotic viability decreases over time, and a product with 50 billion CFU at manufacture may contain far fewer by the time you take it.

3. Appropriate storage conditions Some strains require refrigeration; others are shelf-stable. Follow the manufacturer's storage instructions. Products that claim shelf-stability should ideally have stability data to support this.

4. Third-party testing Independent testing by organizations like USP, NSF International, or ConsumerLab provides some assurance that the product contains what it claims. This is particularly important in the largely self-regulated supplement industry.

5. Evidence for the specific strain(s) Can you find published clinical trials for the specific strain at the dose listed on the label? If the manufacturer cannot point you to peer-reviewed research on their specific strain, that is a significant concern.

6. Single-strain vs. multi-strain considerations Multi-strain products are not inherently superior to single-strain products. Some well-designed multi-strain formulations have clinical evidence, but many are assembled without scientific rationale for the specific combination [mcfarland2017]. If you have a specific health goal, a single strain with targeted evidence is often the more evidence-based choice.

Red flags to watch for:

• Claims to cure or treat diseases (supplements cannot legally make these claims)
• Proprietary blends that hide individual strain amounts
• Extremely high CFU counts marketed as a selling point without supporting evidence
• Broad, vague claims like "supports overall wellness" without citing specific research

For more on how probiotics compare to prebiotics and whether you might benefit from both, see our prebiotics vs. probiotics guide. To learn more about specific probiotic organisms, explore our microbiome database or visit our page on digestive health goals.

Frequently Asked Questions

See the FAQ section at the top of this article for structured answers to the most common questions about choosing the best probiotics.

References

All references are cited inline using AMA format. See the reference list in the article metadata for full citation details.